From 1502028ba62d3fd3f0b0d55577b72dd070e96e68 Mon Sep 17 00:00:00 2001 From: XinlingWang0628 <105673895+XinlingWang0628@users.noreply.github.com> Date: Wed, 26 Jun 2024 10:26:44 -0400 Subject: [PATCH] Addpmid (#2041) * Add pmid and citation * update citation --------- Co-authored-by: XinlingWang00 Co-authored-by: Ramya Madupuri <34350829+rmadupuri@users.noreply.github.com> --- public/gist_msk_2023/meta_study.txt | 2 ++ public/mixed_msk_tcga_2021/meta_study.txt | 4 +++- public/msk_ch_2023/meta_study.txt | 2 +- public/rectal_msk_2019/meta_study.txt | 4 +++- public/ucec_ccr_cfdna_msk_2022/meta_study.txt | 4 +++- 5 files changed, 12 insertions(+), 4 deletions(-) diff --git a/public/gist_msk_2023/meta_study.txt b/public/gist_msk_2023/meta_study.txt index 2358f8781f..494584c23c 100644 --- a/public/gist_msk_2023/meta_study.txt +++ b/public/gist_msk_2023/meta_study.txt @@ -2,3 +2,5 @@ cancer_study_identifier: gist_msk_2023 type_of_cancer: gist name: Gastrointestinal Stromal Tumors (MSK, Clin Cancer Res 2023) description: Targeted sequencing of 469 gastrointestinal stromal tumors and their matched normals via MSK-IMPACT. +pmid: 37477937 +citation: Dermawan et al. Clin Cancer Res 2023 \ No newline at end of file diff --git a/public/mixed_msk_tcga_2021/meta_study.txt b/public/mixed_msk_tcga_2021/meta_study.txt index a46a51f9d1..ded977a334 100644 --- a/public/mixed_msk_tcga_2021/meta_study.txt +++ b/public/mixed_msk_tcga_2021/meta_study.txt @@ -2,4 +2,6 @@ type_of_cancer: mixed cancer_study_identifier: mixed_msk_tcga_2021 name: RAD51B Associated Mixed Cancers (Mandelker 2021) short_name: RAD51B (Mandelker) -description: Germline RAD51B loss-of-function variants confer susceptibility to hereditary breast and ovarian cancers and result in homologous recombination-deficient tumors \ No newline at end of file +description: Germline RAD51B loss-of-function variants confer susceptibility to hereditary breast and ovarian cancers and result in homologous recombination-deficient tumors +pmid: 34635660 +citation: Setton et al. NPJ Breast Cancer 2021 \ No newline at end of file diff --git a/public/msk_ch_2023/meta_study.txt b/public/msk_ch_2023/meta_study.txt index c1c6f8938f..4ce5ec7723 100644 --- a/public/msk_ch_2023/meta_study.txt +++ b/public/msk_ch_2023/meta_study.txt @@ -3,4 +3,4 @@ type_of_cancer: mixed name: Cancer Therapy and Clonal Hematopoiesis (MSK, Blood Adv 2023) description: Targeted sequencing of 47,532 patient samples with mixed tumor types and their matched normals to identify clonal hematopoiesis mutations using MSK-IMPACT. pmid: 38147626 -citation: Stonestrom et al. Blood Adv 2023 +citation: Stonestrom et al. Blood Adv 2024 \ No newline at end of file diff --git a/public/rectal_msk_2019/meta_study.txt b/public/rectal_msk_2019/meta_study.txt index 21613c7646..1487602926 100644 --- a/public/rectal_msk_2019/meta_study.txt +++ b/public/rectal_msk_2019/meta_study.txt @@ -3,4 +3,6 @@ description: MSK-IMPACT targeted sequencing of matched rectal cancer tumor and t groups: SAUVEC;ZHENGY1;SELCUKLS;SANCHEZF;SMITHJ5;PUBLIC name: Rectal Cancer (MSK,Nature Medicine 2019) short_name: Rectal (MSK, 2019) -type_of_cancer: coadread \ No newline at end of file +type_of_cancer: coadread +pmid: 31591597 +citation: Ganesh et al. Nat Med 2019 \ No newline at end of file diff --git a/public/ucec_ccr_cfdna_msk_2022/meta_study.txt b/public/ucec_ccr_cfdna_msk_2022/meta_study.txt index 6d6539cb63..1994337fa9 100644 --- a/public/ucec_ccr_cfdna_msk_2022/meta_study.txt +++ b/public/ucec_ccr_cfdna_msk_2022/meta_study.txt @@ -2,4 +2,6 @@ type_of_cancer: ucec cancer_study_identifier: ucec_ccr_cfdna_msk_2022 name: Endometrial Carcinoma cfDNA (MSK, Clin Cancer Res 2022) short_name: UCEC cfDNA MSK 2022 -description: High-sensitivity mutation analysis of cell-free DNA for disease monitoring in endometrial cancer. \ No newline at end of file +description: High-sensitivity mutation analysis of cell-free DNA for disease monitoring in endometrial cancer. +pmid: 36007103 +citation: Ashley et al. Clin Cancer Res 2023 \ No newline at end of file